Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Intensity Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies

NCT00818961 is registered in ClinicalTrials.gov with Northside Hospital, Inc. as lead sponsor.

NCT NCT00818961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00818961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Intensity Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
Lead sponsor
Northside Hospital, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2005
Completion date
March 31, 2012
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma, myelodysplastic syndromes, myelodysplastic/myeloproliferative diseases